Main Menu
Menu

Resources

Publish Date
Resources
Letters
C4IP Letter to Senate Judiciary Committee RE: IDEA Act
Council for Innovation Promotion
Resources
Public Comments
C4IP Comments RE: 2024 Guidance Update on Patent Subject Matter Eligibility, Including on Artificial Intelligence (PTO-P-2024-0026)
Council for Innovation Promotion
Resources
Reports
Overview of the USPTO Drug Exclusivity Report
Council for Innovation Promotion
Resources
Letters
C4IP Letter to Senate HELP Committee RE: The Medication Affordability and Patent Integrity Act
Council for Innovation Promotion
Resources
Public Comments
C4IP Comments RE: The Impact of the Proliferation of Artificial Intelligence on Prior Art, the Knowledge of a Person Having Ordinary Skill in the Art, and Determinations of Patentability Made in View of the Foregoing (PTO-P-2023-0044)
Council for Innovation Promotion
Resources
Letters
C4IP Letter to House Judiciary Committee RE: IP Litigation and the U.S. International Trade Commission
Council for Innovation Promotion
Resources
Public Comments
C4IP Comments RE: Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting (PTO-P-2024-0003)
Council for Innovation Promotion
Resources
Public Comments
C4IP Comments RE: Patent Trial and Appeal Board Rules of Practice for Briefing Discretionary Denial Issues, and Rules for 325(d) Considerations, Instituting Parallel and Serial Petitions, and Termination Due to Settlement Agreement (PTO-P-2023-0048)
Council for Innovation Promotion
Resources
Public Comments
C4IP Comments RE: Rules Governing Director Review of Patent Trial and Appeal Board Decisions (PTO-P-2024-0014)
Council for Innovation Promotion
Resources
Letters
C4IP Letter to House Judiciary Committee RE: SHOP SAFE Act
Council for Innovation Promotion
Resources
Letters
C4IP Letter to House Judiciary Committee RE: Third-Party Litigation Funding
Council for Innovation Promotion
Resources
Letters
C4IP Letter to Senate Judiciary Committee RE: The PREVAIL Act
Council for Innovation Promotion
Resources:

Resources:

C4IP Letter to Senate Judiciary Committee RE: IDEA Act,

09/17/2024
Resources:

Resources:

C4IP Comments RE: 2024 Guidance Update on Patent Subject Matter Eligibility, Including on Artificial Intelligence (PTO-P-2024-0026),

09/16/2024
Resources:

Resources:

Overview of the USPTO Drug Exclusivity Report,

09/12/2024
Resources:

Resources:

C4IP Letter to Senate HELP Committee RE: The Medication Affordability and Patent Integrity Act,

08/26/2024
Resources:

Resources:

C4IP Comments RE: The Impact of the Proliferation of Artificial Intelligence on Prior Art, the Knowledge of a Person Having Ordinary Skill in the Art, and Determinations of Patentability Made in View of the Foregoing (PTO-P-2023-0044),

07/29/2024
Resources:

Resources:

C4IP Letter to House Judiciary Committee RE: IP Litigation and the U.S. International Trade Commission,

07/22/2024
Resources:

Resources:

C4IP Comments RE: Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting (PTO-P-2024-0003),

07/09/2024
Resources:

Resources:

C4IP Comments RE: Patent Trial and Appeal Board Rules of Practice for Briefing Discretionary Denial Issues, and Rules for 325(d) Considerations, Instituting Parallel and Serial Petitions, and Termination Due to Settlement Agreement (PTO-P-2023-0048),

06/18/2024
Resources:

Resources:

C4IP Comments RE: Rules Governing Director Review of Patent Trial and Appeal Board Decisions (PTO-P-2024-0014),

06/17/2024
Resources:

Resources:

C4IP Letter to House Judiciary Committee RE: SHOP SAFE Act,

06/13/2024
Resources:

Resources:

C4IP Letter to House Judiciary Committee RE: Third-Party Litigation Funding,

06/12/2024
Resources:

Resources:

C4IP Letter to Senate Judiciary Committee RE: The PREVAIL Act,

06/10/2024
Scroll to Top